Smith, Salley & Associates Ginkgo Bioworks Holdings, Inc. Transaction History

Smith, Salley & Associates

  • $1.48 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024
BUY
$1.06 - $1.67 $31,800 - $50,100
30,000 Added 125.0%
54,000 $62,000
Q4 2023

Jan 24, 2024
BUY
$1.26 - $1.79 $15,120 - $21,480
12,000 Added 100.0%
24,000 $40,000
Q3 2023

Oct 27, 2023
BUY
$1.61 - $2.54 $19,320 - $30,480
12,000 New
12,000 $21,000

Others Institutions Holding DNA

# of Institutions
41
Shares Held
48.1M
Call Options Held
0
Put Options Held
0
View Full List

About Ginkgo Bioworks Holdings, Inc.

DNA Quotes by TradingView
  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $10.2B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Smith, Salley & Associates Portfolio

Follow Smith, Salley & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith, Salley & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Smith, Salley & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email